Gates Foundation CEO Steps Down and Former CDC Director Dumps $9.11 Million in Shares of Merck Stock

Gates Foundation CEO Steps Down and Former CDC Director Dumps $9.11 Million in Shares of Merck Stock


Nearly lost in all the noise over the impeachment debacle and constant fear-mongering surrounding the “coronavirus” outbreak, were two notable events involving major career vaccine pushers.

In December 2019, news quietly broke that Sue Desmond-Hellman would be stepping down as CEO of Bill & Melinda Gates Foundation. Even more quiet was her announcement 2 months earlier that she would be stepping down as lead director on the board at Facebook.

Vox reported that her departure is due to sudden health issues:

Now, it appears health issues are causing her to step aside. Desmond-Hellmann also held power as a lead independent director on the board of Facebook, which she announced she was leaving this fall.

And as if that wasn’t newsworthy enough in itself, news of another event came across my Twitter feed about former CDC director Julie Gerberding, who is currently enjoying her revolving door rite of passage as an executive at Merck, sold $9.11 million in shares of Merck stock this month.

I had to do a double-take on that 9.11 number before I went to verify it from another source. Sure enough, as also reported by Slater Sentinel and SEC filings, it’s accurate.

And there’s more! Apparently Gerberding still sits on shares valuing over $9 million more.

That’s another $9 million more coming if Merck doesn’t tank:

Merck & Co., Inc. (NYSE:MRK) EVP Julie L. Gerberding sold 102,073 shares of the business’s stock in a transaction on Monday, January 13th. The stock was sold at an average price of $89.34, for a total transaction of $9,119,201.82. Following the sale, the executive vice president now owns 106,099 shares in the company, valued at $9,478,884.66.The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

This is by far the most value in shares Gerberding’s ever sold in one transaction in the last 10 years since she became the president of Merck’s vaccine division, in 2009. The last time she pulled out millions worth in one transaction like this, as we reported a year ago, came only one day before the 2016 presidential election of Donald Trump and amounted to $5.6 million. Before that it was $2.3 million in 2015.

Only time will tell if the timing of these two announcements had anything to do with other world events currently unfolding before the public’s eyes.

Makes you wonder.

Do they know something that the public should know about? It wouldn’t be the first time…stay vigilant!

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *